Machine Learning in Drug Development: Part 1
Gebonden Engels 2025 9780443413650Levertijd ongeveer 9 werkdagen
Gratis verzonden
Samenvatting
Machine Learning in Drug Development: Part One, Volume 64 in the Annual Reports on Medicinal Chemistry series, highlights new advances in the field. Chapters in this release include Artificial Intelligence in Small Molecule and Nucleic Acid Research: A Review, AI-aided Drug Development for Protein Degraders: Design, Lead Identification, and Optimization, AI-aided Drug Development for Protein Degraders: Biology Validation, Disease-association, Drug Repurposing, Transforming Modern Drug Discovery with Machine Learning, Artificial Intelligence in the Development of Antiviral Drugs: Progress and Applications, Artificial Intelligence for Drug Target Identification, and Machine Learning in Proteomic Biomarker Discovery.
Specificaties
Lezersrecensies
Wees de eerste die een lezersrecensie schrijft!
Inhoudsopgave
1. Artificial Intelligence in Small Molecule and Nucleic Acid Research: A Review<br>2. AI-aided Drug Development for Protein Degraders: Design, Lead Identification, and Optimization<br>3. AI-aided Drug Development for Protein Degraders: Biology Validation, Disease-association, Drug Repurposing<br>4. Transforming Modern Drug Discovery with Machine Learning<br>5. Artificial Intelligence in the Development of Antiviral Drugs: Progress and Applications<br>6. Artificial Intelligence for Drug Target Identification<br>7. Machine Learning in Proteomic Biomarker Discovery
Rubrieken
- advisering
- algemeen management
- coaching en trainen
- communicatie en media
- economie
- financieel management
- inkoop en logistiek
- internet en social media
- it-management / ict
- juridisch
- leiderschap
- marketing
- mens en maatschappij
- non-profit
- ondernemen
- organisatiekunde
- personal finance
- personeelsmanagement
- persoonlijke effectiviteit
- projectmanagement
- psychologie
- reclame en verkoop
- strategisch management
- verandermanagement
- werk en loopbaan